Penn Pharma has secured multiple contracts with companies in Europe, the U.S., and Japan less than two months after officially opening the doors of its new high potency manufacturing facility.   The facility was designed to meet the growing market need for contained manufacturing processes. According to a company statement, “Successfully securing multiple global contracts in such a short space of time has verified Penn’s vision and investment strategy that led to the design and build of th...